The myocardial no-reflow phenomenon: Role of δPKC

Cardiovascular Research

Volumn 73, Issue 4, 2007, Pages 623-625

  Wilson, Gregory J ^a,b,c   Diaz, Roberto J ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C DELTA;

ACUTE HEART INFARCTION; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CORONARY ARTERY BLOOD FLOW; EDITORIAL; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE PERFUSION; HEART OUTPUT; ISCHEMIC HEART DISEASE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; VASCULAR RESISTANCE; VASOCONSTRICTION;

HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OLIGOPEPTIDES; PROTEIN KINASE C-DELTA;

EID: 33846859346     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.01.004     Document Type: Editorial

References (9)

1. Ikeno F., Inagaki K., Rezaee M., and Mochly-Rosen D. Impaired perfusion after myocardial infarction is due to reperfusion-induced δPKC-mediated myocardial damage. Cardiovasc Res 73 (2007) 699-709
2. Reffelmann T., and Kloner R.A. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 101 (2006) 359-372
3. Galiuto L., and Crea F. No-reflow: a heterogeneous clinical phenomenon with multiple therapeutic strategies. Curr Pharm Des 12 (2006) 3807-3815
4. Kloner R.A., Rude R.E., Carlson N., Maroko P.R., DeBoer L.W., and Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?. Circulation 62 (1980) 945-952
5. Reffelmann T., and Kloner R.A. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?. Am J Physiol Heart Circ Physiol 284 (2003) H1134-H1141
6. Hara M., Saikawa T., Tsunematsu Y., Sakata T., and Yoshimatsu H. Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction. J Atheroscler Thromb 12 (2005) 315-321
7. Iijima R., Shinji H., Ikeda N., Itaya H., Makino K., Funatsu A., et al. Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome. Am J Cardiol 97 (2006) 29-33
8. Porto I., Ashar V., and Mitchell A.R. Pharmacological management of no reflow during percutaneous coronary intervention. Curr Vasc Pharmacol 4 (2006) 95-100
9. Forman M., Stone G., and Jackson E. Role of adenosine as adjuntive therapy in acute myocardial infarction. Cardiovasc Drug Rev 24 (2006) 116-147